C-Terminal Protein Sequencing in Biopharmaceuticals
C-Terminal protein sequencing analysis is a technique that precisely analyzes the carboxyl-terminal sequence of proteins or polypeptides. This technique is crucial for identifying C-terminal amino acid sequences, detecting modifications at the C-terminal, and confirming the completeness of protein processing. The C-terminal sequences play significant roles in various biological processes, including the regulation of protein stability, functional activity, interactions, and signal transduction. Moreover, biopharmaceutical products such as monoclonal antibodies, fusion proteins, and recombinant proteins often undergo C-terminal modifications or truncations during production, which can impact their efficacy and safety.
Key applications of C-Terminal protein sequencing include quality control of biopharmaceuticals, analysis of protein post-translational modifications (PTMs), research into protein degradation mechanisms, and the identification of novel biomarkers. For instance, in the field of biopharmaceuticals, C-terminal truncation can affect the structural stability and bioactivity of antibodies, necessitating detailed characterization through C-Terminal protein sequencing to ensure consistency and safety. In studies of protein degradation, specific cleavage patterns at the C-terminal are linked to particular disease states, such as the different neurotoxic properties of Alzheimer's disease-associated amyloid-beta (Aβ) C-terminal variants. In research on protein post-translational modifications, the C-terminal can undergo phosphorylation, acylation, glycosylation, or tyrosine sulfation, which are critical for the regulation of protein functions. Thus, C-Terminal protein sequencing analysis not only reveals structural details but also provides insights into the biological function of proteins.
Currently, methods for C-Terminal protein sequencing include chemical degradation, enzymatic digestion, and mass spectrometry. Traditional Edman degradation has been largely replaced by more efficient mass spectrometry due to its limitations in identifying C-terminal sequences. Substrate-specific proteases, such as carboxypeptidases, can be utilized to sequentially release amino acids from the C-terminal, facilitating sequence analysis when combined with mass spectrometry. High-resolution mass spectrometry-based techniques, such as LC-MS/MS, have become the preferred method for C-terminal sequencing. Strategies involving C-terminal specific labeling combined with mass spectrometry detection and proteolytic fragment analysis via mass spectrometry are effective in elucidating C-terminal sequences.
C-Terminal protein sequencing analysis faces challenges due to the low stability of C-terminal regions, which makes them susceptible to enzymatic and chemical modifications. Therefore, experiments must be carefully optimized regarding protease selection, buffer conditions, and mass spectrometry parameters. In cases where the C-terminal is blocked, such as through acylation, specific chemical reagents are required to remove modifications and ensure sequencing accuracy. For complex protein mixtures, C-terminal sequencing often necessitates the use of protein purification techniques like SDS-PAGE, affinity purification, or HPLC fractionation to enhance detection sensitivity and specificity.
MtoZ Biolabs leverages extensive proteomics research expertise and advanced analytical technology to offer protein N/C-terminal sequencing services. By applying innovative C-terminal specific enzymatic digestion techniques coupled with high-resolution mass spectrometry platforms, we provide precise analyses of C-Terminal protein sequencing. This supports biopharmaceutical companies in optimizing drug development and improving product quality control.
MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.
Related Services
How to order?
